| Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
|---|---|---|---|
| USD 20.37 Billion | USD 27.92 Billion | CAGR at 3.57% | 2023 |
According to the report published by Zion Market Research, the global Dry Powder Inhaler Market size was valued at USD 20.37 Billion in 2023 and is predicted to reach USD 27.92 Billion by the end of 2032. The market is expected to grow with a CAGR of 3.57% during the forecast period. The report analyzes the global Dry Powder Inhaler Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Dry Powder Inhaler Market industry.
Request Free SampleRequest Free Sample
Dry powder inhaler is a medical device that is used for the effective delivery of medication to the lungs. The medication comes in the form of dry powder. The patients who suffer from various respiratory diseases make use of the dry powder inhalers as they are portable and are easy to carry.
The market player Inspiro Medical has developed the product Inspiromatic™ which is an advanced version of the dry powder inhalers. The device has an active dry powder fluidization mechanism which works in the low inhalation flow rates.
The global market for the dry powder inhaler is fragmented into its product type, application, and end-user industry.
Based on the product type, the global market is segregated into multi-dose dry powder inhaler and single dose dry powder inhaler.
Based on the application, the market is categorized into COPD, cardiovascular diseases, asthma, diabetes, cystic fibrosis, and others.
Based on the end-user industry, the market is divided into home & personal care and clinics & hospitals.
Request Free SampleRequest Free Sample
The patients that suffer from different types of respiratory diseases have a major concern regarding taking of accurate dosage of medicines. The factors that are contributing to the growth of the market are the rise in the number of the cases being registered of respiratory disease and the rise in the aging population increases the demand for the dry powder inhalers. The market players are trying to develop various innovations in the devices that are used for the inhalation purposes thus propelling the growth of the market.
The opportunities for the market are increasing as the manufacturers are trying to use new methods such as computational fluid dynamics for the development of the new generation products. The factors that are limiting the growth of the market are these devices are not resistant to moisture thus if the medicine comes in contact with moisture it loses its properties and the availability of the other competitive products in the market such as electric pumps and nebulizers.
| Report Attributes | Report Details |
|---|---|
| Report Name | Dry Powder Inhaler Market Research Report |
| Market Size in 2023 | USD 20.37 Billion |
| Market Forecast in 2032 | USD 27.92 Billion |
| Growth Rate | CAGR of 3.57% |
| Number of Pages | 196 |
| Key Companies Covered | Cipla Inc., GlaxoSmithKline Plc., Teicos Pharma Ltd., Presspart Manufacturing Ltd., Beximco Pharma Ltd., Catalent, Inc., Hovione FarmaCiencia SA., AstraZeneca Plc., Bespak Europe Ltd., Luckys Pharma, and SRS Pharmaceuticals Pvt. Ltd. |
| Segments Covered | By Product type, By Application, By end-user industry and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The market for the dry powder inhaler is dominated by the North American region. The major factor that contributes to the market growth is the early adoption of the advanced medical technologies in this region. Europe is following the North American region and is expected to grow rapidly in the coming years owing to the presence of the major pharmaceutical companies in this region. There are huge investments made by the market players for the development of the healthcare sector in this region. In Asia Pacific region, the market will grow at a good speed owing to the increasing disposable income and the developing economy in the region. In Asia Pacific region, there is a significant growth in the geriatric population which is increasing the demand for the dry powder inhalers.
The key market players that are involved in the dry powder inhaler market include:
By Product type
By Application
By end-user industry
Dry Powder Inhaler Market: Regional Segment Analysis
By Region
What Reports Provides
FrequentlyAsked Questions
A dry powder inhaler is a medical device that delivers powdered medication to the lungs. It is commonly used to treat asthma and respiratory diseases.
The global dry powder inhaler market is expected to be driven by the The market is driven by rising respiratory diseases, preference for needle-free drug delivery, and advancements in inhalation devices.
According to study, the global dry powder inhaler market size was worth around USD 20.37 Billion in 2023 and is predicted to grow to around USD 27.92 Billion By 2032.
The global dry powder inhaler market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 3.57% during the forecast period from 2024-2032.
The global dry powder inhaler industry is projected to be challenged by Challenges include formulation stability issues, strict regulatory approvals, and patient usability concerns. Competition from alternative drug delivery methods persists.
The Opportunities include rising asthma/COPD prevalence, shift to propellant-free inhalers, and growth in generics. Improved device usability and digital dose tracking support differentiation will offer significant growth opportunities in the dry powder inhaler market.
Next-gen formulations with improved lung deposition; low-resistance airflow and ergonomic designs; digital dose counters & connected adherence tracking are the emerging trends and innovations impacting the dry powder inhaler market.
The global dry powder inhaler market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global dry powder inhaler market are; Cipla Inc., GlaxoSmithKline Plc., Teicos Pharma Ltd., Presspart Manufacturing Ltd., Beximco Pharma Ltd., Catalent, Inc., Hovione FarmaCiencia SA., AstraZeneca Plc., Bespak Europe Ltd., Luckys Pharma, and SRS Pharmaceuticals Pvt. Ltd. and others.
The report explores crucial aspects of the dry powder inhaler market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients